healthcare
Waterland-backed Rehacon bolts on Fysioconcept
Waterland acquired a majority stake in physiotherapy provider Rehacon in January 2019
Ampersand to acquire Vibalogics
Ampersand typically invests $10-50m in companies with $10-100m in annual revenues
Steadfast Capital to buy W Söhngen
Steadfast will use its fourth vehicle for the investment in the medicine products manufacturer
Ardian acquires Sintetica
In 2018, Sintetica reported revenues of CHF 75m, up from approximately CHF 60m in 2017
Sofinnova closes MD Start III Fund on €48m
MD Start, which is a group of three funds, was started by Sofinnova Partners in 2010
BIVF, UCB Ventures lead £1.4m round for Rinri
Representatives from BIVF, UCB Ventures and BioCity have joined the company's board of directors
SHS invests in Betterguards
Betterguards is SHS's third investment from SHS V, which held its first close in 2018 on €90m
Yabeo-backed CommitMed merges with Prosenio
Prosenio, the merged company, will generate more than €16m in sales and will employ 60 people
VCs sell Therachon to Pfizer for $810m
Pfizer will acquire Therachon for $340m with $470m in additional, conditional payments
Ampersand takes minority stake in GenDX
Ampersand typically invests $10-50m in companies with $10-100m in annual revenue
BioGeneration, Wellington lead €30m series-A for Confo
Fund+ and Perceptive Advisors, Capricorn, Qbic, PMV, Mints, V-Bio Ventures and VIB joined the round
Panakès Partners in CHF 9.5m round for SamanTree
Panakès Partners is using equity from its Fund I, which invests €5-6m in European startups
Consortium invests CHF 12.5m in Alentis
BioMedPartners, BB Pureos Bioventures, BPI France, Schroder Adveq and HTGF participate in the deal
VCs in funding round for Cevec
Peppermint Venture, NRW Bank and Creathor Ventures raised €4.5m for Cevec in 2015
HTGF-backed Immunic lists on Nasdaq
Consortium including LSP, Bayern Kapital, HTGF and IBG reinvested €26.7m in Immunic
BPI leads €13m series-A for NH TherAguix
Omnes Capital, BPI France and investment management firm Arbevel are new investors
Ardian to acquire Sintetica
Sintetica recorded revenue of approximately €60m for 2018 and employs around 300 staff
Waterland-backed Rehacon bolts on Anita Brüche
Waterland acquired a majority stake in Rehacon, a physiotherapy provider, in January 2019
Consortium raises €21m for AgomAb
Representatives from V-Bio, Advent Biotechnology, BIVF, Omnes and Pontifax have joined the board
Sofinnova, NEA in CHF 22.5m funding round for Polyneuron
Polyneuron develops biodegradable glycopolymers for the treatment of autoimmune diseases
Impilo acquires The Fertility Partnership
New owner will support the expansion of TFP's offering and its international growth
Waterland exits Zentrum Gesundheit to Nord in SBO
Vendor has also launched sale processes for Median Kliniken and fertility group VivaNeo
IK supports Klingel's acquisitions of Bächler, Gehring
Klingel is an IK VIII fund company and was acquired by the firm in 2018 from Halder
Omnes, M Capital Partners lead €5m round for Therapixel
Therapixel won the Dream Digital Mammography Challenge in 2017, winning €1.2m in prize money